Optic nerve sheath changes after therapy in giant cell arteritis
Part of Brain & nervous system, Eyes & vision, Heart & circulation, Immune system & allergy, Skin clinical trials.
This study looks at how quickly the optic nerve sheath (the protective layer around the eye nerve) changes after starting treatment for giant cell arteritis (GCA), a condition that causes inflammation in blood vessels. It aims to see if these changes can help doctors monitor the disease and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be taking part in the SONIC-GCA study and have had a baseline ultrasound of the optic nerve sheath.
- You must have a confirmed diagnosis of giant cell arteritis (GCA) based on the SONIC-GCA assessment.
- You must have started treatment with steroids (like prednisone) within the last 48 hours and have taken no more than 160 mg in total before the baseline visit.
- You must be able to give informed consent and agree to follow the intensive follow-up schedule of this study.
- You cannot be taking part in another blinded drug trial at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a quick ultrasound of the optic nerve (plus an eye exam) can help evaluate new suspected giant cell arteritis (GCA). It may help doctors assess eye risk early and decide on the best next steps.
This study looks at how vision is affected in people with giant cell arteritis (GCA) -- a condition where blood vessels become inflamed. It compares those with GCA-related vision loss to people who have similar vision problems but not from GCA, to better understand and treat these eye issues.
This study looks at changes in blood cells that may happen in giant cell arteritis (GCA), a condition that causes inflammation in blood vessels. By comparing people with GCA to healthy volunteers, researchers hope to find clues that might help diagnose or treat the disease earlier.
This study uses an ultrasound of the temporal artery (a vessel in your temple) to see if certain findings can predict whether giant cell arteritis will come back. It may help doctors know who needs closer monitoring.
This trial tests how well a special MRI (picture scan) can evaluate giant cell arteritis when it’s newly suspected and symptoms started recently. It may help doctors confirm the diagnosis and decide on treatment sooner by comparing MRI findings with standard testing like biopsy or ultrasound.
This study checks whether different MRI scanning details can better help doctors diagnose giant cell arteritis. If you’re being sent for an injected MRI because GCA is suspected, your scan results may help improve how future diagnoses are made.
Hear when a new Giant Cell Arteritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.